These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 28925976)

  • 1. Shiga Toxin Therapeutics: Beyond Neutralization.
    Hall G; Kurosawa S; Stearns-Kurosawa DJ
    Toxins (Basel); 2017 Sep; 9(9):. PubMed ID: 28925976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shiga toxin-induced haemolytic uraemic syndrome and the role of antibiotics: a global overview.
    Kakoullis L; Papachristodoulou E; Chra P; Panos G
    J Infect; 2019 Aug; 79(2):75-94. PubMed ID: 31150744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The A1 Subunit of Shiga Toxin 2 Has Higher Affinity for Ribosomes and Higher Catalytic Activity than the A1 Subunit of Shiga Toxin 1.
    Basu D; Li XP; Kahn JN; May KL; Kahn PC; Tumer NE
    Infect Immun; 2016 Jan; 84(1):149-61. PubMed ID: 26483409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of complement monoclonal antibody eculizumab in Shiga toxin producing Escherichia coli associated hemolytic uremic syndrome: A review of current evidence.
    Mahat U; Matar RB; Rotz SJ
    Pediatr Blood Cancer; 2019 Nov; 66(11):e27913. PubMed ID: 31286658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shiga toxin-producing Escherichia coli infection.
    Thorpe CM
    Clin Infect Dis; 2004 May; 38(9):1298-303. PubMed ID: 15127344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Particulate Shiga Toxin 2 in Blood is Associated to the Development of Hemolytic Uremic Syndrome in Children.
    Brigotti M; He X; Carnicelli D; Arfilli V; Porcellini E; Galassi E; Tazzari PL; Ricci F; Patfield SA; Testa S; Paglialonga F; Picicco D; Caprioli A; Scavia G; Morabito S; Ardissino G
    Thromb Haemost; 2020 Jan; 120(1):107-120. PubMed ID: 31858520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Shiga-toxigenic Escherichia coli isolated from cases of diarrhoea & haemolytic uremic syndrome in north India.
    Kumar A; Taneja N; Bharti B; Sharma M
    Indian J Med Res; 2014 Dec; 140(6):778-84. PubMed ID: 25758577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Recent Therapeutic Applications and the Infection Strategies of Shiga Toxin-Producing
    Hwang SB; Chelliah R; Kang JE; Rubab M; Banan-MwineDaliri E; Elahi F; Oh DH
    Front Cell Infect Microbiol; 2021; 11():614963. PubMed ID: 34268129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperhydration to Improve Kidney Outcomes in Children with Shiga Toxin-Producing E. coli Infection: a multinational embedded cluster crossover randomized trial (the HIKO STEC trial).
    Freedman SB; Schnadower D; Estes M; Casper TC; Goldstein SL; Grisaru S; Pavia AT; Wilfond BS; Metheney M; Kimball K; Tarr PI;
    Trials; 2023 May; 24(1):359. PubMed ID: 37245030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extrarenal manifestations of the hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli (STEC HUS).
    Khalid M; Andreoli S
    Pediatr Nephrol; 2019 Dec; 34(12):2495-2507. PubMed ID: 30382336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic use of a receptor mimic probiotic reduces intestinal Shiga toxin levels in a piglet model of hemolytic uremic syndrome.
    Hostetter SJ; Helgerson AF; Paton JC; Paton AW; Cornick NA
    BMC Res Notes; 2014 Jun; 7():331. PubMed ID: 24890228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of children with Shiga toxin-associated haemolytic uraemic syndrome treated with eculizumab: a matched cohort study.
    Monet-Didailler C; Chevallier A; Godron-Dubrasquet A; Allard L; Delmas Y; Contin-Bordes C; Brissaud O; Llanas B; Harambat J
    Nephrol Dial Transplant; 2020 Dec; 35(12):2147-2153. PubMed ID: 31411695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Therapeutic Developments against Shiga Toxin-Producing Escherichia coli.
    Melton-Celsa AR; O'Brien AD
    Microbiol Spectr; 2014 Oct; 2(5):. PubMed ID: 26104346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic strategies for Shiga toxin-producing Escherichia coli infections.
    Rogers TJ; Paton JC
    Expert Rev Anti Infect Ther; 2009 Aug; 7(6):683-6. PubMed ID: 19681694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-Time PCR Assay for Detection and Differentiation of Shiga Toxin-Producing Escherichia coli from Clinical Samples.
    Qin X; Klein EJ; Galanakis E; Thomas AA; Stapp JR; Rich S; Buccat AM; Tarr PI
    J Clin Microbiol; 2015 Jul; 53(7):2148-53. PubMed ID: 25926491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One problem, multiple potential targets: Where are we now in the development of small molecule inhibitors against Shiga toxin?
    Tucker SK; McHugh RE; Roe AJ
    Cell Signal; 2024 Sep; 121():111253. PubMed ID: 38852937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of the Shiga toxin in the hemolytic uremic syndrome].
    Creydt VP; Nuñez P; Boccoli J; Silberstein C; Zotta E; Goldstein J; Ibarra C
    Medicina (B Aires); 2006; 66 Suppl 3():11-5. PubMed ID: 17354471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An epidemiologic surveillance of Shiga-like toxin-producing Escherichia coli infection in Argentinean children: risk factors and serum Shiga-like toxin 2 values.
    López EL; Contrini MM; Glatstein E; Ayala SG; Santoro R; Ezcurra G; Teplitz E; Matsumoto Y; Sato H; Sakai K; Katsuura Y; Hoshide S; Morita T; Harning R; Brookman S
    Pediatr Infect Dis J; 2012 Jan; 31(1):20-4. PubMed ID: 21829137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of STEC Gastroenteritis: Is There a Role for Probiotics?
    Giordano M; Baldassarre ME; Palmieri V; Torres DD; Carbone V; Santangelo L; Gentile F; Panza R; Di Mauro F; Capozza M; Di Mauro A; Laforgia N
    Int J Environ Res Public Health; 2019 May; 16(9):. PubMed ID: 31083597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiplex real-time PCR assay for detection of Escherichia coli O157:H7 and screening for non-O157 Shiga toxin-producing E. coli.
    Li B; Liu H; Wang W
    BMC Microbiol; 2017 Nov; 17(1):215. PubMed ID: 29121863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.